News

BlackDoctor.org21h
Clinical Trial Shows Dupixent Works As Well in Dark Skin As It Does in Others
Learn how Dupixent helps diverse eczema patients and why inclusive clinical trials are vital for fair healthcare.
MarketBeat on MSN1h
Nektar Jumps 157% on Drug Trial Data-Can It Go Even Higher?
Nektar Therapeutics (NASDAQ: NKTR) stock exploded nearly 157% following news that Rezpeg, the company’s experimental ...
Arcutis Biotherapeutics: A Closer Look At The Atopic Dermatitis Direction
Arcutis is financially strong, with over 30 months of cash runway. The atopic dermatitis market is large and shifting away ...
Healio22h
Topline atopic dermatitis data showcase IL-2 modulator’s ‘incredibly novel’ mechanism
Rezpegaldesleukin, an investigational interleukin-pathway agonist, demonstrated efficacy and safety for people with moderate ...
The Munich Eye20h
Increasing Vaccine Acceptance Among Older Adults Supported by New Research
Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.
The Munich Eye20h
No Pay for Tattoo-Related Illness
Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.